Second wave of C-19 ‘less severe’ than the first: ICMR

The symptoms of joint ache, fatigue, muscle ache, loss of smell or sore throat are much less compared to the first wave

226
ICMR

Dr Balram Bhargava, Director-General (DG) of the Indian Council of Medical Research (ICMR) on Monday said that the ongoing second wave of the novel C-19 virus in India is ‘less severe’ than the previous one.

Dr Bhargava said: “Very clearly, we find that the symptoms are much less. As I mentioned that the symptoms of joint ache, fatigue, muscle ache, loss of smell or sore throat are much less compared to the first wave.

However, shortness of breath is higher in this wave.” He further said that only a marginally high proportion of d-19 patients are of younger age and that the average of patients in the first wave was 50 years and in this wave, it is 49 years.

Mask Lady
Picture: Pixabay

He also said that the older population continues to be more vulnerable to be admitted in the hospital in the current wave.

“From zero to 19 years – the difference was 5.8 percent versus 4.2 percent, and in 20-40 years, the difference was 25 percent versus 23 percent. There is a marginal difference in this. More than 70 per cent were above or equal to 40 years of age. A higher number of asymptomatic individuals got admitted this year, than a higher proportion of patients admitted with breathlessness,” he said.


Also read:

Latest Circulars, Notices & Guidelines: CDSCO, DCGI

New Regulatory Regime for 8 Medical Devices under D&C Act

New price of Remdesivir injection, prices reduced by 7 companies: NPPA

Import of drugs with residual shelf life: deadline extended till October…

Sun Pharma, Alembic recall products in the US market

860 doses of Remdesivir injections stolen from Govt Hospital


“There is no change in the death rate between the first wave and the second wave. Similar trends are being seen across all the states because this is a countrywide data of a national registry data which has been collected of only hospitalised patients, so this is 10,000 hospitalised patients that are being analysed,” added Dr Bhargava.

The ICMR chief further opined that there was a tremendous amount of laxity regarding the pandemic and many instances of C-inappropriate behaviour was also seen. He also stressed that the RT-PCR test measures two or more genes in the body and there is no chance of missing the detection of a C-19 mutant through the test.

“I would like to emphasise that the RT-PCR test that we are utilising, they measure two or more genes and they never miss a test… We have always used two or more genes for testing and therefore missing is absolutely impossible… It can find any kind of mutant because it measures two or more genes at different sites,” he said.

Dr Bhargava further said that the rate of transmissibility of the ‘double mutant’ found in India has not yet been established.

Three main variants from the United Kingdom, South Africa and Brazil have already been found in India.

As the second wave of the C-19 virus intensifies, India yet again reported the highest single-day spike of C-19 cases with over 2.73 lakh fresh infections and 1,619 deaths in the last 24 hours.

With this, the total number of positive cases in the country to 1,50,61,919. There are currently 19,29,329 active cases in the country as of Monday. The death toll reached 1,78,769 as of Monday.


Enter your email address:

Delivered by FeedBurner

Latest updates

The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram.

Go to main website, click here

Follow and connect with us on Facebook and Linkedin

For daily free updates on WhatsApp, click here

Subscribe here for daily updates
Loading